180 related articles for article (PubMed ID: 23873335)
1. Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice.
Rezende BM; Bernardes PT; Resende CB; Arantes RM; Souza DG; Braga FC; Castor MG; Teixeira MM; Pinho V
Mar Drugs; 2013 Jul; 11(7):2595-615. PubMed ID: 23873335
[TBL] [Abstract][Full Text] [Related]
2. PI3Kγ controls leukocyte recruitment, tissue injury, and lethality in a model of graft-versus-host disease in mice.
Castor MG; Rezende BM; Bernardes PT; Vieira AT; Vieira EL; Arantes RM; Souza DG; Silva TA; Teixeira MM; Pinho V
J Leukoc Biol; 2011 Jun; 89(6):955-64. PubMed ID: 21402770
[TBL] [Abstract][Full Text] [Related]
3. Lithothamnion muelleri treatment ameliorates inflammatory and hypernociceptive responses in antigen-induced arthritis in mice.
Costa VV; Amaral FA; Coelho FM; Queiroz-Junior CM; Malagoli BG; Gomes JH; Lopes F; Silveira KD; Sachs D; Fagundes CT; Tavares LD; Pinho V; Silva TA; Teixeira MM; Braga FC; Souza DG
PLoS One; 2015; 10(3):e0118356. PubMed ID: 25793994
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality.
Castor MG; Rezende BM; Resende CB; Bernardes PT; Cisalpino D; Vieira AT; Souza DG; Silva TA; Teixeira MM; Pinho V
J Leukoc Biol; 2012 Apr; 91(4):629-39. PubMed ID: 22301794
[TBL] [Abstract][Full Text] [Related]
5. The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice.
Castor MG; Rezende B; Resende CB; Alessandri AL; Fagundes CT; Sousa LP; Arantes RM; Souza DG; Silva TA; Proudfoot AE; Teixeira MM; Pinho V
J Immunol; 2010 Mar; 184(5):2646-54. PubMed ID: 20100934
[TBL] [Abstract][Full Text] [Related]
6. Antiadhesive activity of polysaccharide-rich fractions from Lithothamnion muelleri.
Soares CM; Malagoli BG; Menezes GB; Pinho V; Souza DG; Teixeira MM; Braga FC
Z Naturforsch C J Biosci; 2012; 67(7-8):391-7. PubMed ID: 23016278
[TBL] [Abstract][Full Text] [Related]
7. Nanocomposite treatment reduces disease and lethality in a murine model of acute graft-versus-host disease and preserves anti-tumor effects.
Bernardes PT; Rezende BM; Resende CB; De Paula TP; Reis AC; Gonçalves WA; Vieira EG; Pinheiro MV; Souza DG; Castor MG; Teixeira MM; Pinho V
PLoS One; 2015; 10(4):e0123004. PubMed ID: 25875016
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response.
Berg BB; Soares JS; Paiva IR; Rezende BM; Rachid MA; Cau SBA; Romero TRL; Pinho V; Teixeira MM; Castor MGME
J Pharmacol Exp Ther; 2021 May; 377(2):273-283. PubMed ID: 33658314
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.
Wang H; Asavaroengchai W; Yeap BY; Wang MG; Wang S; Sykes M; Yang YG
Blood; 2009 Apr; 113(15):3612-9. PubMed ID: 19211507
[TBL] [Abstract][Full Text] [Related]
10. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
Murai M; Yoneyama H; Harada A; Yi Z; Vestergaard C; Guo B; Suzuki K; Asakura H; Matsushima K
J Clin Invest; 1999 Jul; 104(1):49-57. PubMed ID: 10393698
[TBL] [Abstract][Full Text] [Related]
11. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of Graft Anti-Host Cytotoxic T Lymphocytes Along with Allogeneic Bone Marrow Skips Macrophage-Induced Graft-Versus-Host Disease.
Yoshida R; Yamana H; Hayashi M; Yasuda E; Shibayama Y; Hirose Y; Tanigawa N; Uchiyama K; Kubota T
J Interferon Cytokine Res; 2021 Sep; 41(9):310-318. PubMed ID: 34543129
[TBL] [Abstract][Full Text] [Related]
13. P-selectin and P-selectin glycoprotein ligand 1 mediate rolling of activated CD8+ T cells in inflamed colonic venules.
Asaduzzaman M; Mihaescu A; Wang Y; Sato T; Thorlacius H
J Investig Med; 2009 Oct; 57(7):765-8. PubMed ID: 19730132
[TBL] [Abstract][Full Text] [Related]
14. Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease.
Miklos S; Mueller G; Chang Y; Bouazzaoui A; Spacenko E; Schubert TEO; Grainger DJ; Holler E; Andreesen R; Hildebrandt GC
Int J Hematol; 2009 Apr; 89(3):383-397. PubMed ID: 19288173
[TBL] [Abstract][Full Text] [Related]
15. Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model).
Azar Y; Shainer R; Almogi-Hazan O; Bringer R; Compton SR; Paidas MJ; Barnea ER; Or R
Biol Blood Marrow Transplant; 2013 Apr; 19(4):519-28. PubMed ID: 23266739
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
[TBL] [Abstract][Full Text] [Related]
17. T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease.
New JY; Li B; Koh WP; Ng HK; Tan SY; Yap EH; Chan SH; Hu HZ
Bone Marrow Transplant; 2002 Jun; 29(12):979-86. PubMed ID: 12098066
[TBL] [Abstract][Full Text] [Related]
18. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
19. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
[TBL] [Abstract][Full Text] [Related]
20. Notch inhibition enhances graft-versus-leukemia while reducing graft-versus-host disease.
Luo X; Xu L; Liu L; Li Y; Tan H
Eur J Pharmacol; 2019 Jan; 843():226-232. PubMed ID: 30445020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
